FR3101546B1 - Masquage du goût de l’isosorbide - Google Patents

Masquage du goût de l’isosorbide Download PDF

Info

Publication number
FR3101546B1
FR3101546B1 FR1911102A FR1911102A FR3101546B1 FR 3101546 B1 FR3101546 B1 FR 3101546B1 FR 1911102 A FR1911102 A FR 1911102A FR 1911102 A FR1911102 A FR 1911102A FR 3101546 B1 FR3101546 B1 FR 3101546B1
Authority
FR
France
Prior art keywords
isosorbide
taste masking
taste
dosage form
masking
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1911102A
Other languages
English (en)
Other versions
FR3101546A1 (fr
Inventor
Bihan Gregory Le
Sebastien Croquet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roquette Freres SA
Original Assignee
Roquette Freres SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roquette Freres SA filed Critical Roquette Freres SA
Priority to FR1911102A priority Critical patent/FR3101546B1/fr
Priority to PCT/FR2020/051766 priority patent/WO2021069836A1/fr
Priority to US17/754,498 priority patent/US20240050375A1/en
Priority to JP2022520491A priority patent/JP2022550858A/ja
Priority to EP20796640.9A priority patent/EP4041197A1/fr
Publication of FR3101546A1 publication Critical patent/FR3101546A1/fr
Application granted granted Critical
Publication of FR3101546B1 publication Critical patent/FR3101546B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

Abstract

La présente technologie se rapport au masquage du goût de l’isosorbide, en particulier de son amertume. La technologie développée ici propose ainsi une nouvelle forme galénique permettant d’améliorer le goût de l’isosorbide, ainsi qu’un procédé de préparation de cette forme galénique.
FR1911102A 2019-10-07 2019-10-07 Masquage du goût de l’isosorbide Active FR3101546B1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
FR1911102A FR3101546B1 (fr) 2019-10-07 2019-10-07 Masquage du goût de l’isosorbide
PCT/FR2020/051766 WO2021069836A1 (fr) 2019-10-07 2020-10-07 Masquage du goût de l'isosorbide
US17/754,498 US20240050375A1 (en) 2019-10-07 2020-10-07 Masking the taste of isosorbide
JP2022520491A JP2022550858A (ja) 2019-10-07 2020-10-07 イソソルビドの味のマスキング
EP20796640.9A EP4041197A1 (fr) 2019-10-07 2020-10-07 Masquage du goût de l'isosorbide

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1911102A FR3101546B1 (fr) 2019-10-07 2019-10-07 Masquage du goût de l’isosorbide
FR1911102 2019-10-07

Publications (2)

Publication Number Publication Date
FR3101546A1 FR3101546A1 (fr) 2021-04-09
FR3101546B1 true FR3101546B1 (fr) 2023-11-10

Family

ID=70456810

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1911102A Active FR3101546B1 (fr) 2019-10-07 2019-10-07 Masquage du goût de l’isosorbide

Country Status (5)

Country Link
US (1) US20240050375A1 (fr)
EP (1) EP4041197A1 (fr)
JP (1) JP2022550858A (fr)
FR (1) FR3101546B1 (fr)
WO (1) WO2021069836A1 (fr)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2338996A1 (fr) 1998-07-31 2000-02-10 Otsuka Pharmaceutical Co., Ltd. Composition pharmaceutique ayant un gout ameliore
JP4264105B2 (ja) * 2004-06-24 2009-05-13 株式会社三和化学研究所 イソソルビド含有ゼリー製剤
KR101406231B1 (ko) * 2007-01-10 2014-06-12 세츠코 다케다 메니에르병 치료약

Also Published As

Publication number Publication date
WO2021069836A1 (fr) 2021-04-15
US20240050375A1 (en) 2024-02-15
FR3101546A1 (fr) 2021-04-09
EP4041197A1 (fr) 2022-08-17
JP2022550858A (ja) 2022-12-05

Similar Documents

Publication Publication Date Title
MA55193B1 (fr) Procédés de préparation d'un inhibiteur de pi3k
EA201992873A1 (ru) Получение фосфатных производных
MX2017009028A (es) Formas cristalinas novedosas de maleato de neratinib y procedimiento de preparacion de las mismas.
MX2021002854A (es) Ciclacion enzimatica de acido homofarnesilico.
MA45843A (fr) Dérivés d'oxadiazolopyridine utilisés comme inhibiteurs de la ghréline o-acyl transférase (chèvre)
MX2019013872A (es) Metodo para producir material no tejido de celulosa sintetizada bacterianamente.
FR3101546B1 (fr) Masquage du goût de l’isosorbide
MY195300A (en) (6r,10r)-6,10,14-trimetylpentadecan-2-one prepared from 6,10-dimetylundec-5-en-2-one or 6,10-dimetylundeca-5,9-dien-2-one
FR3070831B1 (fr) Procede de preparation d'une composition a base de proteines de legumineuses
EA202091340A1 (ru) Способ получения соединений "лекарственное средство-линкер"
FR3102178B1 (fr) Polyamides gélifiants biosourcés
MX2019009242A (es) Un proceso novedoso para la sintesis de 1-aril-1-trifluoro-metil-c iclopropanos.
BR112022007102A2 (pt) Métodos para a preparação de ácido 5-bromo-2-(3-cloro-piridin-2-il)-2h-pirazol-3-carboxílico
FR3061410B1 (fr) Composition biostimulante de la croissance des plantes obtenue a partir de surnageant de culture de souches bacillus sp.
EA202190330A1 (ru) Способ получения полиморфной формы робенакоксиба
EA201792655A1 (ru) Способ синтеза 9,9-бис(гидроксиметил)флуорена
DE602007005117D1 (de) Herstellungsverfahren für pyrazolhaltige verbindungen
NZ732381A (en) Tosylate salt of n-[3-[(4ar,7as)-2-amino-6-(5-fluoropyrimidin-2-yl)-4,4a,5,7-tetrahydropyrrolo[3,4-d][1,3]thiazin-7a-yl]-4-fluoro-phenyl]-5-methoxy-pyrazine-2-carboxamide
FR3016166B1 (fr) Procede de fabrication du bromo methyl cyclopropane et du bromo methyl cyclobutane
FR3102176B1 (fr) Corn steep soluble
FR3096981B1 (fr) Composition à base de poudre de silicium pour la production d’hydrogène
EA201992384A1 (ru) Способ получения пиперазинового кольца для синтеза производных пиразинокарбазола
EA201992726A1 (ru) Способ получения (s,s)-секоизоларицирезинола диглюкозида и (r,r)-секоизоларицирезинола диглюкозида
MX2019000385A (es) Metodo para producir una forma polimorfica de 3-[5-amino-4-(3-cianobenzoilo)-pirazol-1-il]-n-ciclopropil-4-meti lbenzamida.
FR3073737B1 (fr) La methode de traitement de la rhinosinusite

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20210409

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5